(Q38096477)

28 August 2017

title

Treatment of hepatocellular carcinoma: present and future (English)

1 reference

28 August 2017

main subject

hepatocellular carcinoma

1 reference

Chiara Genco

1

1 reference

28 August 2017

Giuseppe Cabibbo

2

1 reference

28 August 2017

Giuseppe Cabibbo

3

1 reference

28 August 2017

Marcello Maida

4

1 reference

28 August 2017

Giuseppe Brancatelli

5

1 reference

28 August 2017

Massimo Galia

6

1 reference

28 August 2017

Nicola Alessi

7

1 reference

28 August 2017

Giuseppe Butera

8

1 reference

28 August 2017

Claudio Genova

9

1 reference

28 August 2017

Piero Romano

10

1 reference

28 August 2017

Maurizio Raineri

11

1 reference

28 August 2017

Antonello Giarratano

12

1 reference

28 August 2017

Massimo Midiri

13

1 reference

28 August 2017

Calogero Cammà

14

1 reference

28 August 2017

publication date

1 April 2013

1 reference

Expert Review of Anticancer Therapy

28 August 2017

published in

1 reference

28 August 2017

volume

13

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

469-479

1 reference

Global cancer statistics, 2002

28 August 2017

cites work

1 reference

Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance

21 January 2018

1 reference

21 January 2018

Hepatocellular carcinoma

1 reference

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

Management of hepatocellular carcinoma: An update

21 January 2018

1 reference

Hepatocellular cancer: optimal strategies for screening and surveillance

21 January 2018

1 reference

Novel advancements in the management of hepatocellular carcinoma in 2008.

21 January 2018

1 reference

Cost analysis of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma.

21 January 2018

1 reference

Management of hepatocellular carcinoma

21 January 2018

1 reference

Prognosis of hepatocellular carcinoma: the BCLC staging classification

21 January 2018

1 reference

Diagnosis and Treatment of Hepatocellular Carcinoma

21 January 2018

1 reference

A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma

21 January 2018

1 reference

Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study

21 January 2018

1 reference

Resection and liver transplantation for hepatocellular carcinoma.

21 January 2018

1 reference

Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients

21 January 2018

1 reference

Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma

21 January 2018

1 reference

A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

21 January 2018

1 reference

Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma.

21 January 2018

1 reference

Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.

21 January 2018

1 reference

Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: Ethanol injection therapy and radiofrequency ablation

21 January 2018

1 reference

Image-guided ablation for hepatocellular carcinoma

21 January 2018

1 reference

Needle track seeding following percutaneous procedures for hepatocellular carcinoma

21 January 2018

1 reference

A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma

21 January 2018

1 reference

Local-regional treatment of hepatocellular carcinoma

21 January 2018

1 reference

High-intensity focused ultrasound for hepatocellular carcinoma: a single-center experience.

21 January 2018

1 reference

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

21 January 2018

1 reference

Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria

21 January 2018

1 reference

Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging

21 January 2018

1 reference

Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis

21 January 2018

1 reference

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

21 January 2018

1 reference

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

21 January 2018

1 reference

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

21 January 2018

1 reference

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

21 January 2018

1 reference

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

21 January 2018

1 reference

Clinical outcome of 251 patients with extrahepatic metastasis at initial diagnosis of hepatocellular carcinoma: does transarterial chemoembolization improve survival in these patients?

21 January 2018

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma

21 January 2018

1 reference

Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be?

21 January 2018

1 reference

Multimodal approaches to the treatment of hepatocellular carcinoma

21 January 2018

1 reference

Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial.

21 January 2018

1 reference

Does chemotherapy prevent HCV-related hepatocellular carcinoma? Pros

21 January 2018

1 reference

A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma.

21 January 2018

1 reference

Causes of and prevention strategies for hepatocellular carcinoma.

21 January 2018

1 reference

Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: a meta-analysis

21 January 2018

1 reference

Management of cirrhotic patients with hepatocellular carcinoma treated with sorafenib

21 January 2018

1 reference

Should cirrhosis change our attitude towards treating non-hepatic cancer?

21 January 2018

1 reference

Linking molecular classification of hepatocellular carcinoma and personalized medicine: preliminary steps.

21 January 2018

1 reference

Sorafenib: where do we go from here?

21 January 2018

1 reference

Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma

21 January 2018

1 reference

Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma

21 January 2018

1 reference

Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma.

21 January 2018

1 reference

Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study

21 January 2018

1 reference

Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study

21 January 2018

1 reference

Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer

21 January 2018

1 reference

Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer

21 January 2018

1 reference

RAD001 (everolimus) inhibits tumour growth in xenograft models of human hepatocellular carcinoma

21 January 2018

1 reference

Targeted therapies for hepatocellular carcinoma.

21 January 2018

1 reference

Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma

21 January 2018

1 reference

The intermediate hepatocellular carcinoma stage: Should treatment be expanded?

21 January 2018

1 reference

Seeding after radiofrequency ablation of hepatocellular carcinoma in patients with cirrhosis: A prospective study

21 January 2018

1 reference

Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation

21 January 2018

1 reference

Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERA.13.21

1 reference

28 August 2017

1 reference